ETAHX Holdings — Eventide Healthcare & Life Sciences Fund
Data updated: 2026-09-11
ETAHX holds 93 securities. The top 10 make up 32.4% of net assets, led by Guardant Health (5.37%) and US Bank Mmda - Usbgfs 9 (3.75%). Health Care (93.2%) and Funds & ETFs (1.4%) are the largest sectors, and 90.2% of the portfolio is in United States. Debt holdings: 1 position, under 0.1% of assets.
Holdings cover 101.04% of net asset value (99.92% of total assets; remainder is cash and receivables). As of June 30, 2026 · N-PORT.
ETAHX Portfolio Holdings
93 holdings of Eventide Healthcare & Life Sciences Fund by percentage of net assets, from the fund's SEC N-PORT filing as of June 30, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Guardant Health | GH | Health Care | 5.37% | $96.07M |
| US Bank Mmda - Usbgfs 9 | — | Unknown | 3.75% | $67.01M |
| Mirum Pharmaceut | MIRM | Health Care | 3.47% | $62.08M |
| Kymera Therapeut | KYMR | Health Care | 3.22% | $57.68M |
| Abivax SA-ADR | ABVX | Health Care | 2.94% | $52.61M |
| Belite Bio, Inc. | — | Health Care | 2.83% | $50.60M |
| Trevi Therapeuti | TRVI | Health Care | 2.77% | $49.61M |
| Mbx Biosciences | MBX | Health Care | 2.69% | $48.22M |
| Vaxcyte, Inc. | PCVX | Health Care | 2.69% | $48.10M |
| Cytokinetics, Inc. | CYTK | Health Care | 2.69% | $48.05M |
| Argenx SE - ADR | ARGX | Health Care | 2.55% | $45.64M |
| Ionis Pharmaceut | IONS | Health Care | 2.55% | $45.59M |
| Insmed, Inc. | INSM | Health Care | 2.40% | $43.01M |
| Revolution Medic | RVMD | Health Care | 2.36% | $42.18M |
| Avalyn Pharma, Inc. | — | Health Care | 2.35% | $41.99M |
| Immix Biopharma | IMMX | Health Care | 2.24% | $40.12M |
| Celldex Therapeu | CLDX | Health Care | 2.16% | $38.59M |
| Palvella Therape | PVLA | Health Care | 1.98% | $35.38M |
| Kestra Medical T | KMTS | Health Care | 1.95% | $34.81M |
| Scholar Rock Hol | SRRK | Health Care | 1.95% | $34.80M |
| Apogee Therapeut | APGE | Health Care | 1.93% | $34.51M |
| Definium Therape | DFTX | Health Care | 1.87% | $33.40M |
| Irhythm Holdings | IRTC | Health Care | 1.85% | $33.04M |
| Bridgebio Pharma | BBIO | Health Care | 1.82% | $32.56M |
| Beta Bionics, Inc. | BBNX | Health Care | 1.80% | $32.16M |
| Nurix Therapeuti | NRIX | Health Care | 1.76% | $31.49M |
| Arrowhead Pharma | ARWR | Health Care | 1.69% | $30.16M |
| Disc Medicine in | IRON | Health Care | 1.62% | $28.91M |
| Ovid Therapeutic | — | Health Care | 1.49% | $26.57M |
| Cg Oncology, Inc. | CGON | Health Care | 1.46% | $26.03M |
| Amylyx Pharmaceu | AMLX | Health Care | 1.33% | $23.80M |
| Oruka Therapeuti | ORKA | Health Care | 1.28% | $22.84M |
| Frst Am-Gv Ob-U | — | Funds & ETFs | 1.25% | $22.36M |
| Dianthus Therape | DNTH | Health Care | 1.23% | $21.96M |
| Sionna Therapeut | SION | Health Care | 1.17% | $20.89M |
| Celcuity, Inc. | CELC | Health Care | 1.14% | $20.46M |
| Glaukos Corp. | GKOS | Health Care | 1.11% | $19.94M |
| Sutro Biopharma | STRO | Health Care | 1.09% | $19.43M |
| Privia Health Gr | PRVA | Health Care | 1.06% | $18.98M |
| Eyepoint Pharmac | EYPT | Health Care | 1.00% | $17.81M |
| Spyre Therapeuti | SYRE | Health Care | 0.99% | $17.76M |
| Heartflow, Inc. | HTFL | Health Care | 0.98% | $17.46M |
| Dexcom | DXCM | Health Care | 0.95% | $17.01M |
| Aktis Oncology I | AKTS | Health Care | 0.91% | $16.34M |
| Achieve Life Sci | ACHV | Health Care | 0.81% | $14.50M |
| United Therapeut | UTHR | Health Care | 0.80% | $14.40M |
| Kardigan, Inc. | KARD | Unknown | 0.80% | $14.22M |
| Axsome Therapeut | AXSM | Health Care | 0.77% | $13.71M |
| Kailera Therapeu | KLRA | Health Care | 0.76% | $13.59M |
| Praxis Precision | PRAX | Health Care | 0.72% | $12.82M |
| Tango Therapeuti | TNGX | Health Care | 0.70% | $12.50M |
| Evommune, Inc. | EVMN | Health Care | 0.70% | $12.49M |
| Kardium Inc. | — | Health Care | 0.60% | $10.82M |
| Oric Pharmaceuticals, Inc. | ORIC | Health Care | 0.58% | $10.30M |
| Belite Bio I-ADR | BLTE | Health Care | 0.54% | $9.58M |
| Bright Minds Bio | DRUG | Health Care | 0.51% | $9.13M |
| Adlai Nortye-ADR | ANL | Health Care | 0.46% | $8.27M |
| Kardigan, Inc. | KARD | Health Care | 0.40% | $7.16M |
| Relmada Therapeutics, Inc. | RLMD | Health Care | 0.39% | $7.03M |
| Adlai Nortye Ltd. | — | Energy | 0.36% | $6.51M |
| Advancell Ser D-1 | — | Unknown | 0.34% | $6.00M |
| Inhibrx Bi | INBX | Health Care | 0.33% | $5.83M |
| Relmada Therapeutics, Inc. | — | Health Care | 0.33% | $5.83M |
| Transmedics Grou | TMDX | Health Care | 0.31% | $5.49M |
| Ovid Therapeutics, Inc. | OVID | Health Care | 0.29% | $5.20M |
| InMed Pharma Inc | — | Health Care | 0.28% | $5.10M |
| Pfizer, Inc.-Cvr | — | Health Care | 0.24% | $4.32M |
| Fid-Mm Govt-I | — | Funds & ETFs | 0.21% | $3.69M |
| Evommune, Inc. | — | Health Care | 0.20% | $3.58M |
| Ovidt Therapeutics Wts | — | Unknown | 0.20% | $3.54M |
| Avalyn Pharma in | AVLN | Health Care | 0.18% | $3.29M |
| Ideaya Bioscienc | IDYA | Health Care | 0.14% | $2.42M |
| Freenome Holdings | FRNOMD | Health Care | 0.13% | $2.28M |
| Peloton Therapeu | — | Health Care | 0.10% | $1.74M |
| Evida Biosciences, Inc. | — | Health Care | 0.05% | $980.82K |
| Flare Therapeutics | — | Health Care | 0.04% | $726.31K |
| Flare Therapeuti | — | Health Care | 0.02% | $408.18K |
| Casma Ser B2 | — | Health Care | 0.02% | $401.93K |
| Casma Therapeuti | — | Health Care | 0.02% | $401.93K |
| Flare Series A Tranche 2 | — | Health Care | 0.02% | $335.62K |
| Freenome | — | Health Care | 0.02% | $327.78K |
| Flare Therapeutics | — | Unknown | 0.01% | $239.09K |
| Casma Therapeutics Ii | — | Health Care | 0.01% | $199.35K |
| Casma Therapeutics | — | Health Care | 0.01% | $146.33K |
| Bispl F 03/12/2027 | — | Unknown | 0.00% | $83.21K |
| Goldfinch Biopharma, Inc. B | — | Health Care | 0.00% | $44.02K |
| Goldfinch Bio B2 | GOLDFB2 | Health Care | 0.00% | $26.58K |
| Goldfinch Bio Ser B Wts | — | Health Care | 0.00% | $0 |
| Kojin Therapeutics, Inc. | KOJINA1 | Unknown | 0.00% | $0 |
| BioSplice Therapeutics | — | Unknown | 0.00% | $0 |
| Goldfinch Biopharma, Inc. | — | Health Care | 0.00% | $0 |
| Kojin Therapeutics | — | Unknown | 0.00% | $0 |
| Biosplice Therapeutics | — | Unknown | 0.00% | $0 |
ETAHX Sector Allocation
Eventide Healthcare & Life Sciences Fund holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 93.2% | 80 |
| Funds & ETFs | 1.4% | 2 |
| Energy | 0.4% | 1 |
| Unknown | 5.0% | 10 |
ETAHX Country Allocation
Where Eventide Healthcare & Life Sciences Fund's holdings are domiciled, by percentage of net assets (largest 6).
| Country | % of net assets |
|---|---|
| United States | 90.2% |
| France | 2.9% |
| Netherlands | 2.5% |
| Canada | 2.4% |
| Bermuda | 1.9% |
| Cayman Islands | 1.0% |
ETAHX Portfolio Allocation
Asset-class allocation of Eventide Healthcare & Life Sciences Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 95.6% |
| Cash & Equivalents | 5.2% |
| Derivatives | 0.2% |
ETAHX Debt Constituents
Largest debt holdings of Eventide Healthcare & Life Sciences Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Biosplice Therapeutics Inc. Series C | 0.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.